These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3025858)

  • 1. Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.
    Mitani M; Cianciolo GJ; Snyderman R; Yasuda M; Good RA; Day NK
    Proc Natl Acad Sci U S A; 1987 Jan; 84(1):237-40. PubMed ID: 3025858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of inactivated feline retrovirus on feline alpha interferon and immunoglobulin production.
    Yasuda M; Good RA; Day NK
    Clin Exp Immunol; 1987 Aug; 69(2):240-5. PubMed ID: 2820639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.
    Cianciolo GJ; Copeland TD; Oroszlan S; Snyderman R
    Science; 1985 Oct; 230(4724):453-5. PubMed ID: 2996136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the immunosuppressive activity of CKS-17, a synthetic retroviral envelope peptide, by muramyl dipeptide.
    Gauduin MC; Vogel FR; Simon JP; Audibert FA; Chedid LA
    Viral Immunol; 1993; 6(3):175-83. PubMed ID: 8292225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus.
    Hebebrand LC; Mathes LE; Olsen RG
    Cancer Res; 1977 Dec; 37(12):4532-3. PubMed ID: 200353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of suppressor cells in feline leukemia virus-associated immunosuppression.
    Langweiler M; Cockerell GL; deNoronha F
    Cancer Res; 1983 May; 43(5):1957-60. PubMed ID: 6299534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
    Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
    Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive actions of retroviruses.
    Good RA; Ogasawara M; Liu WT; Lorenz E; Day NK
    Lymphology; 1990 Jun; 23(2):56-9. PubMed ID: 2170777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ultraviolet-inactivated feline leukemia virus on the production of alpha/beta interferon by feline peripheral blood mononuclear cells.
    Yasuda M; Good RA; Day NK
    Fukuoka Igaku Zasshi; 1992 Nov; 83(11):409-16. PubMed ID: 1336472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte mitogen reactivity in feline leukemia virus-infected cats and identification of feline T and B lymphocytes.
    Cockerell GL; Krakowka S; Hoover EA; Olsen RG; Yohn DS
    Bibl Haematol; 1975 Oct; (43):81-3. PubMed ID: 183735
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of retrovirus suppression of human T cell proliferation in vitro.
    Copelan EA; Rinehart JJ; Lewis M; Mathes L; Olsen R; Sagone A
    J Immunol; 1983 Oct; 131(4):2017-20. PubMed ID: 6311904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.
    Jackson ML; Wood SL; Misra V; Haines DM
    Can J Vet Res; 1996 Jul; 60(3):199-204. PubMed ID: 8809383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication.
    Ito J; Baba T; Kawasaki J; Nishigaki K
    J Virol; 2016 Feb; 90(3):1470-85. PubMed ID: 26581999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus.
    Hebebrand LC; Olsen RG; Mathes LE; Nichols WS
    Cancer Res; 1979 Feb; 39(2 Pt 1):443-7. PubMed ID: 216488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of in vitro neutrophil function by feline leukaemia virus (FeLV) and purified FeLV-p15E.
    Lafrado LJ; Lewis MG; Mathes LE; Olsen RG
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():507-13. PubMed ID: 3029288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic peptide homologous to the envelope proteins of retroviruses shares a cross-reacting epitope with the CD4 receptor.
    Rothmann J; Hassan NF; Campbell DE; Kamani N; Douglas SD
    J Clin Microbiol; 1990 Jan; 28(1):112-5. PubMed ID: 1688871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 Jul; 135(1):583-90. PubMed ID: 2987350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.